A Seven-Year Microbiological and Molecular Study of Bacteremias Due to Carbapenemase-Producing Klebsiella Pneumoniae: An Interrupted Time-Series Analysis …
M Papadimitriou-Olivgeris, C Bartzavali, E Karachalias… - Antibiotics, 2022 - mdpi.com
Background: Ceftazidime/avibactam (CZA) is a new option for the treatment of KPC-
producing Klebsiella pneumoniae. The aim of this study was to determine resistance …
producing Klebsiella pneumoniae. The aim of this study was to determine resistance …
Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae
Antibiotic combinations, including ceftazidime/avibactam (CAZ/AVI), are frequently
employed to combat KPC-producing Klebsiella pneumoniae (KPC-Kp), though such …
employed to combat KPC-producing Klebsiella pneumoniae (KPC-Kp), though such …
Capability of Enterococcus faecalis to shield Gram-negative pathogens from aminoglycoside exposure
TA McMurtry, A Barekat, F Rodriguez… - Journal of …, 2021 - academic.oup.com
Background Enterococcus faecalis commonly produce aminoglycoside-modifying enzymes
(AMEs) and are implicated in polymicrobial infections. Objectives To determine if AME …
(AMEs) and are implicated in polymicrobial infections. Objectives To determine if AME …